Exploratory data show inavolisib benefits persist regardless of hyperglycemia in PIK3CA-mutated breast cancer, with ...

Announced encouraging preliminary safety and efficacy data across all three RAS-pathway inhibitor programs Announced publication in Cancer Discovery highlighting preclinical data demonstrating ...

Extrahepatic cancers have been recognized as a significant outcome of metabolic dysfunction–associated steatotic liver disease (MASLD), which involves ...

Seniors with diabetes who take anti-psychotic medications to control symptoms of dementia may have an increased risk of ending up in hospital, a Canadian-led study suggests. In Monday's issue of the ...

Conference Call and Webcast Today, May 7, 2026, at 4:30 p.m. ETPASADENA, Calif.--(BUSINESS WIRE)--$arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal ...

In this Managed Healthcare Executive Between the Lines video series, Estay Greene, Pharm.D., MBA, and Victoria Bouhairie, M.D ...

FDA's independent advisors on Thursday endorsed the use of capivasertib (Truqap) for treating an aggressive subtype of ...

ODAC voted 7–1 (one abstention) that capivasertib plus abiraterone and ADT shows a favorable benefit–risk profile for ...

Oncologic Drugs Advisory Committee (ODAC) has recognized a favorable benefit risk profile for AstraZeneca's TRUQAP® (capivasertib) in combination with abiraterone and androgen deprivation therapy (ADT ...

In the field of cardiovascular research, dyslipidemia and hyperglycemic conditions are widely recognized as significant risk factors for atherosclerotic ...

Chemotherapy can raise or lower blood sugar, making diabetes management harder during cancer treatment. Certain chemotherapy drugs and steroids can cause hyperglycemia. Insulin is often the best way ...

Blood sugar measures the amount of sugar (glucose) in the bloodstream. High blood sugar (hyperglycemia) raises the risk of prediabetes and type 2 diabetes. Diet changes can lower blood sugar. Cinnamon ...